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Summary
 Background Long-term results of brachytherapy of coronary arteries may be inﬂ uenced by inho-
mogeneity of the dose distribution. The dose distribution perturbations due to the 
presence of stent struts, guide wires and calcium deposits were therefore investigated.
 Aim The aim of the study was to investigate dose distribution perturbations due to 
the presence of stent struts, guide wire and calcium deposits during the irradia-
tion. Both experimental and calculational techniques were applied to elucidate 
these inﬂ uences.
 Materials/Methods The measurements were carried out with radiochromic foil in a phantom in the 
presence and absence of the stent and the guide wire. Due to the measurements 
being limited by the thickness of the detecting foil, the radial dose distribution 
with or without the metallic stent components were also performed using the 
MCNP Monte Carlo code. The same code was used to measure the inﬂ uence of 
cholesterol plaques on dose distribution in the vessel walls.
 Results A large dose reduction in the area shielded by the guide wire was observed. The 
presence of the stent caused a 15% dose reduction behind the struts. The dose 
reduction caused by calcium deposits ranged from 11% to 32%.
 Conclusions These facts may increase the probability of late restenosis after irradiation due to 
underdosage. The inhomogeneity occurring behind the guide wire, stent struts 
and calcium deposits should be taken into account in the analysis of dose distri-
butions for clinical applications.
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BACKGROUND
Long-term results of brachytherapy of coronary 
arteries may be inﬂ uenced by the absolute dose 
and by the possible inhomogeneity of the dose 
distribution. Intracoronary irradiation with beta 
sources is an effective method in reducing ne-
ointimal proliferation after successful angioplasty 
and stent implantation. However, the restenosis 
rate seems to be dose-dependent. Long-term re-
sults may be inﬂ uenced by the absolute dose and 
by the homogeneity in dose distribution. As com-
pared with gamma radiation, beta radiation gen-
erally has a steeper fall-off of the dose because 
of the short range of electrons, so it is important 
to eliminate the factors that can result in atten-
uation of therapeutic dose administration to in-
jured artery segments. Such factors seem to be 
the guide wire present in coronary artery during 
beta-brachytherapy session, the implanted stent, 
and the calcium deposits in the vessel wall [1].
AIM
The aim of the study was to investigate dose dis-
tribution perturbations due to the presence of 
stent struts, guide wire and calcium deposits dur-
ing the irradiation. Both experimental and cal-
culational techniques were applied to elucidate 
these inﬂ uences.
MATERIALS AND METHODS
Measurements
Phantom simulations were used to estimate dose 
distribution perturbations during irradiation 
performed with and without conventional cor-
onary guide wire in position and with and with-
out a stent. The inﬂ uence on dose distribution 
at cylindrical surfaces has been assessed using 
GAF Chromic dosimetric foil MD55 (Nuclear 
AssociatesÒ). The measuring set up is illustrat-
ed in Figure 1 (expanded view). The 5mm wide 
strips of 55 MD GAF Chromic foil were positioned 
within a phantom made of PMMA at radial dis-
tance of 2.5mm from the center of the catheter. A 
Galileo IIIÒ, 3.0mm centering catheter and 0.014’’ 
(0.36mm) Hi-Torque guide wire (both Guidant 
Corporation, Santa Clara, USA) were used [2]. A 
Bolton stent made of L 236 stainless steel, 30mm 
long with 0.2mm diameter struts were used in the 
experiments and calculations. The P-32 radioac-
tive source (GalileoÒ, Guidant radiotherapy sys-
tem) was positioned within the PMMA phantom 
symmetrically to the GAF foil. The irradiation 
time was adjusted to get an optical density in the 
range 1–2. The optical density (in the guide wire 
experiment) was measured by a modiﬁ ed model 
37-443 Densitometer (Nuclear AssociatesÒ) with 
an aperture of 0.5mm, while for the measure-
ments of the effects of stent attenuation a scan-
ner (Microtek Artixscan 1100) was used.
Monte Carlo calculations
The Monte Carlo dose calculations were per-
formed for the vessel reference diameter of 3mm. 
The MCNP4C code was used. The calculations 
were done for calcium deposit plaques of the thick-
ness in the range of 0mm to 1mm [3]. The calci-
um deposit density was assumed as 1.45g/cm3.
RESULTS AND DISCUSSION
Inﬂ uence of the guide wire on dose 
distributions
The optical densities (normalized), presented as 
polar plots, for two runs, with a guide wire present 
during irradiation (full dots) and without guide 
wire (open triangles) are shown in Figure 2. The 
maximum attenuation of beta radiation corre-
sponds to the geometry where the guide wire is 
parallel to the radioactive source [4]. The dose 
is reduced to 54% of its maximal predicted val-
ue in the most “shady” area. The dose reduction 
below 80% occupies a polar sector of almost 60 
degrees and inﬂ uences also the reduction of the 
mean dose delivered to the surface layer to 93% 
of the predicted one.
Inﬂ uence of stent struts on dose distributions
The dose distributions behind the stent struts, 
measured with the GAF foil detector are presented 
in Figure 3. As can be seen from the measurements, 
the presence of the stent causes a dose reduction 
behind the struts of the order of 15%. These meas-
urements have shown the necessity of much deeper 
studies of a stent attenuation, i.e. when the geom-
etry of measurements such as source – stent – de-
tector position are taken into account. These de-
tails have been elucidated by Monte Carlo (MC) 
calculations [5,6]. The model for stent attenuation 
by MC calculation is shown in Figure 4, and the 
results are shown in Figure 5. It can be seen that 
the maximum attenuation of 34% appears at the 
tissue adjacent to a stent strut while at a distance 
of 0.5mm it is less than 5%. The radial dose dis-
tributions for different distances R – 1.55mm to 
2.2mm are shown on Figure 6.
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Figure 1. Expanded view of measuring set up for studying the 
shielding eﬀ ect of the guide wire and the stent struts.
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Figure 2. Polar plots of dose attenuation eﬀ ects of the guide 
wire. Full dots – dose distribution with guide wire present; open 
triangles – dose distribution without guide wire.
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Figure 3. Dose distribution (relative units) along a linear source, 
behind the stent, as measured by the GAF chromic foil – full dots. 
The calculated distributions for R=1.7mm and 1.8mm were added 
to show the consistency of measurements with the calculations.
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Figure 4. The model for stent attennuation by MC calculation.
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Figure 5. Comparison of longitudinal dose distribution at the 
diﬀ erent distances, R(mm), 1.55, 1.6, 1.7, 1.8 and 2.1 from the 
axis of the source.
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Figure 6. Radial dose distributions, with and without a stent, in 
the range of R from 1.55mm to 2.2mm.
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Inﬂ uence of calcium deposits on dose 
distributions
The results of the Monte Carlo dose calculations 
are presented in Table 1. MC simulations indi-
cate that the dose reduction caused by calcium 
deposits range from 11% (0.25mm plaque thick-
ness) to 32% (1mm plaque thickness) at 3mm 
distance from the source. These phenomena may 
increase the probability of the late restenosis af-
ter irradiation due to underdosage.
CONCLUSIONS
The inhomogeneities occurring behind the guide 
wire, stent struts and calcium deposits should be 
taken into account in the analysis of dose distri-
Distance from No Deposit thickness [mm]
The source axis Deposit 0.25 0.5 0.75 1.0
1.6mm 100% 93% 87% 82% 75%
2.5mm 100% 90% 84% 78% 70%
3.0mm 100% 89% 82% 74% 68%
Table 1. Dose reduction behind the calcium deposits. The vessel 
diameter is 3mm. The doses were calculated at three diﬀ erent 
distances from the source axis.
butions for the actual clinical applications and in 
calculating the dose-volume histograms (DVH) 
in the target volume. The results suggest that 
technical improvements in the centering cath-
eter construction should be made to eliminate 
the shielding effect of the guide wire.
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